multiple sclerosis

Opportunities and challenges in the world of ophthalmology in 2018As another year comes to an end, five members of Ophthalmology Times Europe’s Editorial Advisory Board reflect and share their perspectives on the exciting opportunities that lie ahead for ophthalmologists in 2018, whilst also considering the potential challenges.
Why MS relapse rates are underreported: What health execs should knowTwo patient survey studies sponsored by Mallinckrodt reveal findings about patient-reported multiple sclerosis rates.
Know the benefits of adopting neuroimaging
Know the benefits of adopting neuroimagingNeuroimaging can help ODs better treat patients with possible tumor, vascular disorder, or demyelinating disease. CT scans are used for bone fractures and vascular disorders as well as orbital and pituitary tumors. MRIs are best gliomas and menigiomas and screening for vascular disorders. Communicate to radiology patient history and what you are trying to rule out when ordering tests.
Specialty drug pipeline predictions: Seven key areas to watchThe specialty drugs market will see more approvals in 2017 than 2016. Top areas to watch include cancer, multiple sclerosis, and HIV.
Ocrelizumab for Multiple Sclerosis
Ocrelizumab for Multiple SclerosisThe FDA has approved ocrelizumab for treating relapsing forms of multiple sclerosis and primary progressive multiple sclerosis.
Medical marijuana update: Top 3 things health execs should knowHere’s what you need to know about medical marijuana laws, and what they mean for the healthcare system.
FDA approves Bayer’s Bluetooth-enabled auto-injector for multiple sclerosisFDA has approved a supplemental Biologics License Application (sBLA) for Bayer’s myBETAapp and BETACONNECT Navigator for multiple sclerosis (MS) patients
10 More Newly Approved Drugs
10 More Newly Approved DrugsWhat you need to know about the the 10 newest FDA drug approvals.
Integrating pharmacy benefit, medical benefit cuts costsHere’s how one non-profit health plan harnessed the power of medical and pharmacy data to rein in drug costs.
Copay assistance programs: Managed care pros and consDo copay assistance program offer a long-term solution for patients? Experts weigh in.